Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Walsh

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Forensic Science International|May 8, 2019
The identification and quantification of synthetic cannabinoids seized in New Zealand in 2017R F Somerville, V R Hassan, E Kolbe, et al.
Journal of Pharmaceutical Sciences|January 1, 1996
Design and application of a low-temperature Peltier-cooling microscope stageC C Hsu, A J Walsh, H M Nguyen, et al.
Forensic Science International|September 12, 2020
Effects of external influences on synthetic cannabinoid trends in New Zealand, 2014 to 2020C R Stansfield, R F Somerville, V R Hassan, et al.
International Journal of Legal Medicine|July 10, 2015
Simulating backspatter of blood from cranial gunshot wounds using pig modelsG E Radford, M C Taylor, J A Kieser, et al.
Heredity|March 17, 2022
Genomic insights into the historical and contemporary demographics of the grey reef sharkCameron A J Walsh, Paolo Momigliano, Germain Boussarie, et al.
Journal of Crohn'S & Colitis|October 15, 2013
Comparing disease activity indices in ulcerative colitisA J Walsh, A Ghosh, A O Brain, et al.
Plos One|November 9, 2023
Shallow subtidal marine benthic communities of Nachvak Fjord, Nunatsiavut, Labrador: A glimpse into species composition and drivers of their distributionAlan M Friedlander, Enric Ballesteros, Alyssa M Adler, et al.
Alimentary Pharmacology & Therapeutics|January 24, 2017
Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensusL Vuitton, L Peyrin-Biroulet, J F Colombel, et al.
Internal Medicine Journal|November 6, 2014
Dose tailoring of anti-tumour necrosis factor-alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of responseS Ghaly, S Costello, L Beswick, et al.
Internal Medicine Journal|March 4, 2015
Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: the benefits to patientsS P Costello, S Ghaly, L Beswick, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Forensic Science International|May 8, 2019
The identification and quantification of synthetic cannabinoids seized in New Zealand in 2017R F Somerville, V R Hassan, E Kolbe, et al.
Journal of Pharmaceutical Sciences|January 1, 1996
Design and application of a low-temperature Peltier-cooling microscope stageC C Hsu, A J Walsh, H M Nguyen, et al.
Forensic Science International|September 12, 2020
Effects of external influences on synthetic cannabinoid trends in New Zealand, 2014 to 2020C R Stansfield, R F Somerville, V R Hassan, et al.
International Journal of Legal Medicine|July 10, 2015
Simulating backspatter of blood from cranial gunshot wounds using pig modelsG E Radford, M C Taylor, J A Kieser, et al.
Heredity|March 17, 2022
Genomic insights into the historical and contemporary demographics of the grey reef sharkCameron A J Walsh, Paolo Momigliano, Germain Boussarie, et al.
Journal of Crohn'S & Colitis|October 15, 2013
Comparing disease activity indices in ulcerative colitisA J Walsh, A Ghosh, A O Brain, et al.
Plos One|November 9, 2023
Shallow subtidal marine benthic communities of Nachvak Fjord, Nunatsiavut, Labrador: A glimpse into species composition and drivers of their distributionAlan M Friedlander, Enric Ballesteros, Alyssa M Adler, et al.
Alimentary Pharmacology & Therapeutics|January 24, 2017
Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensusL Vuitton, L Peyrin-Biroulet, J F Colombel, et al.
Internal Medicine Journal|November 6, 2014
Dose tailoring of anti-tumour necrosis factor-alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of responseS Ghaly, S Costello, L Beswick, et al.
Internal Medicine Journal|March 4, 2015
Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: the benefits to patientsS P Costello, S Ghaly, L Beswick, et al.
Pageof 3